دورية أكاديمية
Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors.
العنوان: | Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors. |
---|---|
المؤلفون: | Olazarán FE; Facultad de Ciencias Químicas. Av. Universidad s/n, Ciudad Universitaria, San Nicolás de los Garza, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, 64451, México., García-Pérez CA; Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Boulevard del Maestro, s/n, Esq. Elías Piña, Reynosa, Tamualipas, Mexico, 88710., Bandyopadhyay D; Department of Chemistry, The University of Texas Rio Grande Valley, 1201 West University Drive, Edinburg, TX, 78539, USA., Balderas-Rentería I; Facultad de Ciencias Químicas. Av. Universidad s/n, Ciudad Universitaria, San Nicolás de los Garza, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, 64451, México., Reyes-Figueroa AD; Centro de Investigación y de Estudios Avanzados del Instituto Politecnico Nacional, Unidad Monterrey, Apodaca, Nuevo León, 66600, México., Henschke L; Department of Biology, University of Konstanz, Universitätsstraβe 10, 78457, Konstanz, Germany., Rivera G; Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Boulevard del Maestro, s/n, Esq. Elías Piña, Reynosa, Tamualipas, Mexico, 88710. gildardors@hotmail.com. |
المصدر: | Journal of molecular modeling [J Mol Model] 2017 Mar; Vol. 23 (3), pp. 85. Date of Electronic Publication: 2017 Feb 18. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Springer Country of Publication: Germany NLM ID: 9806569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0948-5023 (Electronic) Linking ISSN: 09485023 NLM ISO Abbreviation: J Mol Model Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Berlin : Springer, c1996- |
مواضيع طبية MeSH: | Structure-Activity Relationship*, Polycyclic Aromatic Hydrocarbons/*chemistry , Tubulin/*chemistry , Tubulin Modulators/*chemistry, Binding Sites ; Colchicine/chemistry ; HeLa Cells ; Humans ; Ligands ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Neoplasms/drug therapy ; Neoplasms/genetics ; Small Molecule Libraries ; User-Computer Interface |
مستخلص: | In this work, through a docking analysis of compounds from the ZINC chemical library on human β-tubulin using high performance computer cluster, we report new polycyclic aromatic compounds that bind with high energy on the colchicine binding site of β-tubulin, suggesting three new key amino acids. However, molecular dynamic analysis showed low stability in the interaction between ligand and receptor. Results were confirmed experimentally in in vitro and in vivo models that suggest that molecular dynamics simulation is the best option to find new potential β-tubulin inhibitors. Graphical abstract Bennett's acceptance ratio (BAR) method. |
References: | J Chem Inf Model. 2012 May 25;52(5):1376-90. (PMID: 22530718) J Med Chem. 2010 Dec 23;53(24):8569-84. (PMID: 21080725) Bioorg Med Chem Lett. 2014 Nov 1;24(21):4958-62. (PMID: 25288187) Iran J Pharm Res. 2015 Winter;14(1):141-7. (PMID: 25561920) J Cheminform. 2012 Aug 13;4(1):17. (PMID: 22889332) Eur J Pharmacol. 2015 Aug 5;760:154-62. (PMID: 25912799) J Comput Chem. 2009 Dec;30(16):2785-91. (PMID: 19399780) J Chem Inf Model. 2005 Jan-Feb;45(1):177-82. (PMID: 15667143) Nature. 2004 Mar 11;428(6979):198-202. (PMID: 15014504) Bioorg Med Chem. 2007 Jan 15;15(2):605-15. (PMID: 17070061) Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7. (PMID: 18486472) J Biol Chem. 2014 Jan 31;289(5):2978-91. (PMID: 24338023) Int J Oncol. 1999 Jan;14 (1):103-11. (PMID: 9863015) J Comput Chem. 2004 Oct;25(13):1605-12. (PMID: 15264254) Acta Crystallogr C. 2013 Sep;69(Pt 9):1081-4. (PMID: 24005527) J Pharmacol Exp Ther. 2010 Nov;335(2):302-13. (PMID: 20699436) Int J Mol Med. 2011 May;27(5):715-23. (PMID: 21369694) CA Cancer J Clin. 2015 Mar;65(2):87-108. (PMID: 25651787) Methods. 2015 Jan;71:26-37. (PMID: 25072167) J Mol Graph Model. 2011 Jun;29(7):947-55. (PMID: 21530342) Eur J Med Chem. 2015 Mar 6;92:212-20. (PMID: 25557492) J Comput Chem. 2010 Jan 30;31(2):455-61. (PMID: 19499576) Med Res Rev. 2008 Jan;28(1):155-83. (PMID: 17464966) Methods. 2015 Jan;71:64-70. (PMID: 25171960) Science. 2012 Aug 17;337(6096):857-60. (PMID: 22904013) J Med Chem. 2014 Nov 26;57(22):9370-82. (PMID: 25369367) J Mol Graph Model. 2008 Nov;27(4):497-505. (PMID: 18951052) Onco Targets Ther. 2014 Apr 16;7:575-85. (PMID: 24790457) Curr Top Med Chem. 2008;8(18):1555-72. (PMID: 19075767) J Am Chem Soc. 2010 Dec 15;132(49):17611-6. (PMID: 21087013) Eur J Pharmacol. 2011 Apr 25;657(1-3):4-9. (PMID: 21320484) Bioorg Med Chem Lett. 2004 Oct 4;14 (19):4825-9. (PMID: 15341932) Tetrahedron Lett. 2013 Nov 27;54(48):null. (PMID: 24421568) Bioorg Med Chem. 2011 Oct 15;19(20):6055-68. (PMID: 21920765) J Org Chem. 2014 May 2;79(9):3752-64. (PMID: 24761989) |
فهرسة مساهمة: | Keywords: Anticancer; Colchicine; Inhibitors; Virtual screening; β-Tubulin |
المشرفين على المادة: | 0 (Ligands) 0 (Polycyclic Aromatic Hydrocarbons) 0 (Small Molecule Libraries) 0 (Tubulin) 0 (Tubulin Modulators) SML2Y3J35T (Colchicine) |
تواريخ الأحداث: | Date Created: 20170220 Date Completed: 20180914 Latest Revision: 20181113 |
رمز التحديث: | 20231215 |
DOI: | 10.1007/s00894-017-3256-5 |
PMID: | 28214932 |
قاعدة البيانات: | MEDLINE |
تدمد: | 0948-5023 |
---|---|
DOI: | 10.1007/s00894-017-3256-5 |